Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators. Tumlin JA, et al. Among authors: chawla ls. Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092. Crit Care Med. 2018. PMID: 29509568 Free PMC article.
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.
Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Palevsky PM, et al. Among authors: chawla ls. Clin J Am Soc Nephrol. 2012 May;7(5):844-50. doi: 10.2215/CJN.12791211. Epub 2012 Mar 22. Clin J Am Soc Nephrol. 2012. PMID: 22442182
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.
Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Okusa MD, et al. Among authors: chawla ls. Clin J Am Soc Nephrol. 2012 May;7(5):851-5. doi: 10.2215/CJN.12811211. Epub 2012 Mar 22. Clin J Am Soc Nephrol. 2012. PMID: 22442188
Urinary angiotensinogen and risk of severe AKI.
Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM; SAKInet Investigators. Alge JL, et al. Among authors: chawla ls. Clin J Am Soc Nephrol. 2013 Feb;8(2):184-93. doi: 10.2215/CJN.06280612. Epub 2012 Nov 8. Clin J Am Soc Nephrol. 2013. PMID: 23143504 Free PMC article.
Hemodynamic monitoring in the critical care environment.
Busse L, Davison DL, Junker C, Chawla LS. Busse L, et al. Among authors: chawla ls. Adv Chronic Kidney Dis. 2013 Jan;20(1):21-9. doi: 10.1053/j.ackd.2012.10.006. Adv Chronic Kidney Dis. 2013. PMID: 23265593 Review.
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Kashani K, et al. Among authors: chawla ls. Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503. Crit Care. 2013. PMID: 23388612 Free PMC article. Clinical Trial.
220 results